Topics

Articles

Medical Affairs' changing role in market access and reimbursement

Life sciences companies - including mid-market ones - are finding value in an outsourced service

Outsourced facilities management saves precious financial resources

The full range of healthcare manufacturers should have a unified voice

How about a US Chamber of Healthcare Commerce?

test

The downside of pricing specialty pharmaceuticals too high

Why 'recall readiness' should be top-of-mind for every pharma exec

Continuing problems with compounding pharmacies muddle biopharma’s future direction

Should personalized medicine imply compromised patient safety?

Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products

Why community oncology matters

Managing the specialty pharmacy channel's evolution

In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'

Opinion